Cargando…

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia

Clozapine is an atypical antipsychotic, that is established as the treatment of choice for treatment-resistant schizophrenia (SCZ). To date, no study investigating comprehensive DNA methylation changes in SCZ patients treated with chronic clozapine has been reported. The purpose of the present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Makoto, Numata, Shusuke, Tajima, Atsushi, Yamamori, Hidenaga, Yasuda, Yuka, Fujimoto, Michiko, Watanabe, Shinya, Umehara, Hidehiro, Shimodera, Shinji, Nakazawa, Takanobu, Kikuchi, Masataka, Nakaya, Akihiro, Hashimoto, Hitoshi, Imoto, Issei, Hashimoto, Ryota, Ohmori, Tetsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372645/ https://www.ncbi.nlm.nih.gov/pubmed/28335437 http://dx.doi.org/10.3390/ijms18030632

Ejemplares similares

Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)

Sex differences of leukocytes DNA methylation adjusted for estimated cellular proportions
por: Inoshita, Masatoshi, et al.
Publicado: (2015)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

A significant causal association between C-reactive protein levels and schizophrenia
por: Inoshita, Masatoshi, et al.
Publicado: (2016)

Retraction: A significant causal association between C-reactive protein levels and schizophrenia
por: Inoshita, Masatoshi, et al.
Publicado: (2018)

Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia
por: Kinoshita, Makoto, et al.
Publicado: (2013)

Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia
por: Nishi, Akira, et al.
Publicado: (2014)

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia
por: Kikuchi, Masataka, et al.
Publicado: (2018)

Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis
por: Numata, Shusuke, et al.
Publicado: (2015)

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2018)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Semantic Memory Organization in Japanese Patients With Schizophrenia Examined With Category Fluency
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population
por: Umehara, Hidehiro, et al.
Publicado: (2016)

Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita, Masatoshi, et al.
Publicado: (2018)

PT614. Altered Serotonin transporter mRNA expression in the peripheral leukocytes of obsessive-compulsive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

How to diagnose the 22q11.2 deletion syndrome in patients with schizophrenia: a case report
por: Ohi, Kazutaka, et al.
Publicado: (2013)

A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient
por: Ohi, Kazutaka, et al.
Publicado: (2017)

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2019)

Comparison of eye movements in schizophrenia and autism spectrum disorder
por: Shiino, Tomoko, et al.
Publicado: (2019)

Gene expression-based biological test for major depressive disorder: an advanced study
por: Watanabe, Shin-ya, et al.
Publicado: (2017)

Sensory cognitive abnormalities of pain in autism spectrum disorder: a case–control study
por: Yasuda, Yuka, et al.
Publicado: (2016)

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs
por: Ohi, Kazutaka, et al.
Publicado: (2018)

De novo POGZ mutations in sporadic autism disrupt the DNA-binding activity of POGZ
por: Matsumura, Kensuke, et al.
Publicado: (2016)

Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2017)

S239. PREDICTIVE ACCURACY FOR WORK OUTCOME IN PATIENTS WITH SCHIZOPHRENIA
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Predicting employment status and subjective quality of life in patients with schizophrenia
por: Fujino, Haruo, et al.
Publicado: (2015)

Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan
por: Miki, Kenji, et al.
Publicado: (2018)

Relationship between autistic traits and social functioning in healthy individuals
por: Demizu, Yuria, et al.
Publicado: (2022)

Longitudinal characteristics of insight and clinical factors in patients with schizophrenia
por: Sakai, Yoshie, et al.
Publicado: (2023)

A Naturally Occurring Null Variant of the NMDA Type Glutamate Receptor NR3B Subunit Is a Risk Factor of Schizophrenia
por: Matsuno, Hitomi, et al.
Publicado: (2015)

Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder
por: Hashimoto, Ryota, et al.
Publicado: (2016)

De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity
por: Nishi, Akira, et al.
Publicado: (2017)

The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2013)

Altered sulcogyral patterns of orbitofrontal cortex in a large cohort of patients with schizophrenia
por: Isomura, Shuichi, et al.
Publicado: (2017)

Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects()
por: Kamada, Yoshihiro, et al.
Publicado: (2016)

Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

Role of subcortical structures on cognitive and social function in schizophrenia
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

The p250GAP Gene Is Associated with Risk for Schizophrenia and Schizotypal Personality Traits
por: Ohi, Kazutaka, et al.
Publicado: (2012)

Impaired inhibition of return during free-viewing behaviour in patients with schizophrenia
por: Okada, Ken-ichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n3tlhrs02hsb4d64700bcl1msq